NATERA, INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
NATERA, INC. (NTRA) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $22.69 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2025-02-28
- 2024-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $22.69M.
- 2024-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $29.49M.
- 2024-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $90.30M.
- 2024-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $69.12M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2024-12-31 | $22.69M 10-K · filed 2025-02-28 |
| 2024-09-30 | $29.49M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $90.30M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $69.12M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $236.88M 10-K · filed 2024-02-29 |
| 2023-09-30 | $267.85M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $354.83M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $408.86M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $432.30M 10-K · filed 2023-03-01 |
| 2022-09-30 | $464.11M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $547.35M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $593.66M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $829.90M 10-K · filed 2022-02-25 |
| 2021-09-30 | $928.60M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $517.43M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $588.45M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $688.61M 10-K · filed 2021-02-26 |
| 2020-09-30 | $600.21M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $493.85M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $331.68M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $379.06M 10-K · filed 2020-03-02 |
| 2019-09-30 | $186.70M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $208.05M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $93.81M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $107.46M 10-K · filed 2019-03-15 |
| 2018-09-30 | $130.89M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $70.90M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $80.02M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $106.25M 10-K · filed 2018-03-15 |
| 2017-09-30 | $135.02M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $94.99M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $106.69M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $130.86M 10-K · filed 2017-03-16 |
| 2016-09-30 | $157.72M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $207.49M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $204.86M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $207.55M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |